Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Five Below Inc (FIVE) vs Mesoblast Limited (MESO) Price & Performance

Five Below IncTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Five Below Inc vs Mesoblast Limited — how do they compare? Five Below Inc trades at $200.67 (market cap $10.67B), while Mesoblast Limited trades at $19.05 (market cap $2.31B). The key difference: Five Below Inc is far larger — about 4.6× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Five Below Inc nearer its low. Which is the better fit depends on your goals.

FIVEMESO
Market Cap
$10.67B$2.31B
Sector
Consumer StaplesTechnology
52-Week High
$247.71$20.96
52-Week Low
$131.94$11.35
Enterprise Value
$11.56B$2.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Five Below Inc

Five Below (FIVE) trades at $193.11, up 0.82% with a bullish technical signal despite mixed moving averages. The company demonstrates strong growth with revenue reaching $3.88 billion in 2025 and consistent earnings beats, including Q1 2026 EPS of $2.22 beating expectations of $1.77. Valuation metrics show a P/E of 24.34 and P/S of 2.11, while profitability remains solid with 8.67% net margin and 21.13% ROE. Recent news highlights store expansion to 2,000 locations and strategic investments in digital marketing.

FIVE presents a compelling growth story with analyst consensus pointing to 33% upside potential to $252.09 target. The stock benefits from strong institutional support (60% buy ratings) and positive earnings momentum, though investors should monitor competitive pressures in value retail and the sustainability of expansion-driven cash flow patterns. Current technical levels show support at $191 with resistance at $194.

Mesoblast Limited

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Five Below Inc

Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics

Read more on FIVE

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO